price
GY
NASDAQ · GYRE
Gyre Therapeutics, Inc.
Healthcare · Biotechnology
$4.56
Down-$1.86 (-28.94%)
Updated Oct 31, 2026, 9:52 AM
SID Score
2.6/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 715.86M
- P/E ratio
- 56.8
- Dividend yield
- 0.00%
- 52-week range
- $5.44 – $8.51
- Volume
- 394.08K
- Avg. volume
- 76.81K
Price performance · GYRE
GYRE price history
1M range · 21 trading sessions · Daily adjusted prices
Prices through Oct 30, 2026
GYRE closed at $4.56 after 21 trading sessions, down 35.94% for the selected period.
- Last close
- $4.56
- Period change
- -35.94%
- Period low
- $4.56
- Period high
- $7.35
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 30, 2026 | $6.27 | $6.30 | $4.515 | $4.555 | 394.08K |
| Oct 29, 2026 | $6.86 | $6.985 | $6.37 | $6.41 | 185.32K |
| Oct 28, 2026 | $6.53 | $7.10 | $6.33 | $7.09 | 125.17K |
| Oct 27, 2026 | $6.10 | $6.55 | $6.01 | $6.53 | 126.37K |
| Oct 26, 2026 | $5.77 | $6.0995 | $5.77 | $6.07 | 93.37K |
| Oct 23, 2026 | $5.85 | $5.90 | $5.70 | $5.85 | 151.48K |
| Oct 22, 2026 | $5.91 | $6.00 | $5.80 | $5.86 | 66.58K |
| Oct 21, 2026 | $6.21 | $6.21 | $5.86 | $5.90 | 131.36K |
| Oct 20, 2026 | $6.08 | $6.34 | $6.08 | $6.17 | 242.07K |
| Oct 19, 2026 | $6.10 | $6.2395 | $6.05 | $6.09 | 119.95K |
| Oct 16, 2026 | $6.41 | $6.4314 | $6.04 | $6.08 | 142.88K |
| Oct 15, 2026 | $6.51 | $6.65 | $6.40 | $6.40 | 108.77K |
| Oct 14, 2026 | $6.70 | $6.7514 | $6.442 | $6.47 | 162.85K |
| Oct 13, 2026 | $6.89 | $6.92 | $6.71 | $6.71 | 85.21K |
| Oct 12, 2026 | $7.00 | $7.065 | $6.85 | $6.865 | 81.96K |
| Oct 9, 2026 | $6.80 | $7.09 | $6.76 | $7.04 | 76.63K |
| Oct 8, 2026 | $7.04 | $7.04 | $6.74 | $6.76 | 82.84K |
| Oct 7, 2026 | $7.03 | $7.145 | $6.99 | $7.04 | 99.19K |
| Oct 6, 2026 | $7.42 | $7.42 | $7.01 | $7.08 | 133.97K |
| Oct 5, 2026 | $7.17 | $7.43 | $7.0855 | $7.35 | 181.46K |
| Oct 2, 2026 | $7.09 | $7.35 | $7.08 | $7.11 | 163.75K |
Latest GYRE news
The latest Smart Investors Daily articles mentioning GYRE.
Stock researchResearch & News · SEC Filings
Company
Market Activity
Research & News
Loading stock research…